These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7061664)

  • 21. Species variation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse, and marmoset.
    Eason CT; Spencer AJ; Pattison A; Howells DD; Henry DC; Bonner FW
    Toxicol Appl Pharmacol; 1988 Sep; 95(2):328-38. PubMed ID: 3138789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmolysis, red blood cell partitioning, and plasma protein binding of etofibrate, clofibrate, and their degradation products.
    Altmayer P; Garrett ER
    J Pharm Sci; 1983 Nov; 72(11):1309-18. PubMed ID: 6644594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous GLC determination of clofibrate and clofibric acid in human plasma.
    Wolf MS; Zimmerman JJ
    J Pharm Sci; 1980 Jan; 69(1):92-3. PubMed ID: 7354454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-binding protein: identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liver.
    Lalwani ND; Alvares K; Reddy MK; Reddy MN; Parikh I; Reddy JK
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5242-6. PubMed ID: 3474650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Conjugation reactions of ciprofibrate with human and laboratory animals].
    Oelschläger H; Müller D; Hellwich KH; Ueberall S; Seeling A; Machts H; Hofmann B; Glöckner R
    Arzneimittelforschung; 2003; 53(4):247-53. PubMed ID: 12785120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo distribution of a carcinogenic hepatic peroxisome proliferator: whole-body autoradiography of [14C]ciprofibrate in the mouse.
    Waddell WJ; Marlowe C; Rao MS; Reddy JK
    Carcinogenesis; 1989 Jan; 10(1):221-3. PubMed ID: 2910527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of fibric acid derivatives on blood lipid and lipoprotein levels.
    Hunninghake DB; Peters JR
    Am J Med; 1987 Nov; 83(5B):44-9. PubMed ID: 3318453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. gamma-Glutamyltranspeptidase-negative phenotypic property of preneoplastic and neoplastic liver lesions induced by ciprofibrate does not change following 2-acetylaminofluorene administration.
    Yeldandi AV; Subbarao V; Rajan A; Reddy JK; Rao MS
    Carcinogenesis; 1989 Apr; 10(4):797-9. PubMed ID: 2564815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
    Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
    Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrate.
    Spencer AJ; Barbolt TA; Henry DC; Eason CT; Sauerschell RJ; Bonner FW
    Toxicol Pathol; 1989; 17(1 Pt 1):7-15. PubMed ID: 2501865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of fibric acid derivatives on biliary lipid composition.
    Palmer RH
    Am J Med; 1987 Nov; 83(5B):37-43. PubMed ID: 3318452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rhabdomyolysis under treatment by ciprofibrate in the nephrotic syndrome].
    Baglin A; Lasserre N; Prinseau J; Lebas M
    Therapie; 1987; 42(2):247-8. PubMed ID: 3617003
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye. A model system for the evaluation of xenobiotic-induced effects.
    Rao MS; Thorgeirsson S; Reddy MK; Lalwani ND; Evarts RE; Usman MI; Singh B; Reddy JK
    Am J Pathol; 1986 Sep; 124(3):519-27. PubMed ID: 3532814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate.
    Thangada S; Alvares K; Mangino M; Usman MI; Rao MS; Reddy JK
    FEBS Lett; 1989 Jul; 250(2):205-10. PubMed ID: 2753129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enantiomeric resolution of ciprofibrate and related compounds by HPLC using chiral stationary phases.
    Anderson NH; Johnston D; Vojvodic PR
    J Pharm Biomed Anal; 1992 Jul; 10(7):501-5. PubMed ID: 1420475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Ciprofibrate on platelet aggregation and fibrinolysis in patients with hypercholesterolaemia.
    Simpson IA; Lorimer AR; Walker ID; Davidson JF
    Thromb Haemost; 1985 Aug; 54(2):442-4. PubMed ID: 4082082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction and origin of hepatocytes in rat pancreas.
    Reddy JK; Rao MS; Qureshi SA; Reddy MK; Scarpelli DG; Lalwani ND
    J Cell Biol; 1984 Jun; 98(6):2082-90. PubMed ID: 6202703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of alpha-1 adrenergic receptor inhibits hepatic DNA synthesis stimulated by tumor promoters.
    Tsai WH; Cruise JL; Michalopoulos GK
    Carcinogenesis; 1989 Jan; 10(1):73-8. PubMed ID: 2463115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relative hypolipidaemic activity and hepatic effects of ciprofibrate enantiomers in the rat.
    Graham MJ; Winham MA; Harpur ES; Bonner FW; Gray TJ
    Biochem Pharmacol; 1994 Dec; 48(12):2163-71. PubMed ID: 7811297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-induced hepatocarcinogenesis: levels of activating and detoxifying enzymes in hepatocellular carcinomas induced by ciprofibrate.
    Rao MS; Kokkinakis DM; Subbarao V; Reddy JK
    Carcinogenesis; 1987 Jan; 8(1):19-23. PubMed ID: 3100085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.